Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 1;7(8):e2426774.
doi: 10.1001/jamanetworkopen.2024.26774.

Neuroimaging and Clinical Findings in Healthy Middle-Aged Adults With Mild Traumatic Brain Injury in the PREVENT Dementia Study

Collaborators, Affiliations

Neuroimaging and Clinical Findings in Healthy Middle-Aged Adults With Mild Traumatic Brain Injury in the PREVENT Dementia Study

Audrey Low et al. JAMA Netw Open. .

Abstract

Importance: Traumatic brain injuries (TBI) represent an important, potentially modifiable risk factor for dementia. Despite frequently observed vascular imaging changes in individuals with TBI, the relationships between TBI-associated changes in brain imaging and clinical outcomes have largely been overlooked in community cases of TBI.

Objective: To assess whether TBI are associated with and interact with midlife changes in neuroimaging and clinical features in otherwise healthy individuals.

Design, setting, and participants: This cross-sectional analysis used baseline data from the PREVENT Dementia program collected across 5 sites in the UK and Ireland between 2014 and 2020. Eligible participants were cognitively healthy midlife adults aged between 40 and 59 years. Data were analyzed between January 2023 and April 2024.

Exposure: Lifetime TBI history was assessed using the Brain Injury Screening Questionnaire.

Main outcomes and measures: Cerebral microbleeds and other markers of cerebral small vessel disease (white matter hyperintensities [WMH], lacunes, perivascular spaces) were assessed on 3T magnetic resonance imaging. Clinical measures were cognition, sleep, depression, gait, and cardiovascular disease (CVD) risk, assessed using Computerized Assessment of Information Processing (COGNITO), Pittsburgh Sleep Quality Index, Center for Epidemiologic Studies Depression Scale, clinical interviews, and the Framingham Risk Score, respectively.

Results: Of 617 participants (median [IQR] age, 52 [47-56] years; 380 female [61.6%]), 223 (36.1%) had a history of TBI. TBI was associated with higher microbleed count (β = 0.10; 95% CI, 0.01-0.18; P = .03), with a dose-response association observed with increasing number of TBI events (β = 0.05; 95% CI, 0.01-0.09; P = .03). Conversely, TBI was not associated with other measures of small vessel disease, including WMH. Furthermore, TBI moderated microbleed associations with vascular risk factors and clinical outcomes, such that associations were present only in the absence of TBI. Importantly, observations held when analyses were restricted to individuals reporting only mild TBI.

Conclusions and relevance: In this cross-sectional study of healthy middle-aged adults, detectable changes in brain imaging and clinical features were associated with remote, even mild, TBI in the general population. The potential contribution of vascular injury to TBI-related neurodegeneration presents promising avenues to identify potential targets, with findings highlighting the need to reduce TBI through early intervention and prevention in both clinical care and policymaking.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Malhotra reported leading a National Institute for Health and Care Research (NIHR)-funded NorAD study (PB-PG-0214-33098) with research materials provided via a drugs-only grant from Takeda Pharmaceuticals; he reported receiving research funding from Dementias Platform UK and the UK Medical Research Council outside the submitted work. Dr Koychev reported receiving grants from Novo Nordisk, the Medical Research Council, and the NIHR, as well as personal fees from Novo Nordisk, during the conduct of the study; he reported receiving personal fees from Five Lives SAS, Cognes Ltd, and Cognetivity outside the submitted work. Dr C. Ritchie reported that he was founder and majority shareholder for Scottish Brain Sciences, which holds contracts with Lilly, Roche Diagnostics, Merck, Signant Health, Biogen, and Janssen Cilag outside the submitted work. Dr Stewart reported grants from National Institute of Neurological Disorders and Stroke, the Football Association, Federation Internationale de Football Association, and the Medical Research Council during the conduct of the study. Dr O’Brien reported consulting work with TauRx, Novo Nordisk, Biogen, Roche, Lilly, GE Healthcare outside the submitted work; he reported service as member of boards or data and safety monitoring boards for TauRx, Axon, Eisai outside the submitted work; and he reported receiving grants from Avid and Lilly, Merck, and Alliance Medical outside the submitted work. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Cerebral Microbleeds Associated With Modifiable Vascular Risk Factors in the Absence of TBI History
Interaction analyses were conducted using general linear regression models fitted to each variable of interest in separate models, adjusting for sex, age, education, and study site. In panel A, dots indicate Framingham Risk Score results for individual participants. APOE4 indicates apolipoprotein E ε4; CMB, cerebral microbleeds; CVD, cardiovascular disease risk; TBI, traumatic brain injury. aP < .05.
Figure 2.
Figure 2.. Cerebral Microbleeds Associated With Poorer Clinical Outcomes in the Absence of TBI History
Interaction analyses were conducted using linear regression models fitted to each variable of interest in separate models, adjusting for sex, age, education, and study site. In panels A and B, dots represent individual measures of clinical outcomes. CMB indicates cerebral microbleeds; TBI, traumatic brain injury. aP < .05.
Figure 3.
Figure 3.. Relative Contribution of Risk Factors on Clinical Outcome Measures
Bar heights represent standardized general dominance statistics, which may be interpreted as the relative weight of contribution to R2. BP indicates blood pressure; HDL, high-density lipoprotein; TBI, traumatic brain injury.

References

    1. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413-446. doi: 10.1016/S0140-6736(20)30367-6 - DOI - PMC - PubMed
    1. Hay J, Johnson VE, Smith DH, Stewart W. Chronic traumatic encephalopathy: the neuropathological legacy of traumatic brain injury. Annu Rev Pathol. 2016;11(1):21-45. doi: 10.1146/annurev-pathol-012615-044116 - DOI - PMC - PubMed
    1. Johnson VE, Stewart W, Arena JD, Smith DH. Traumatic Brain Injury as a Trigger of Neurodegeneration. In: Beart P, Robinson M, Rattray M, Maragakis NJ, eds. Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets. Springer International Publishing; 2017:383-400. doi: 10.1007/978-3-319-57193-5_15 - DOI
    1. Griffin AD, Turtzo LC, Parikh GY, et al. Traumatic microbleeds suggest vascular injury and predict disability in traumatic brain injury. Brain. 2019;142(11):3550-3564. doi: 10.1093/brain/awz290 - DOI - PMC - PubMed
    1. Toth L, Czigler A, Horvath P, et al. The effect of mild traumatic brain injury on cerebral microbleeds in aging. Front Aging Neurosci. 2021;13:717391. doi: 10.3389/fnagi.2021.717391 - DOI - PMC - PubMed

Publication types